Intensive Care Medicine Experimentalжурнал

Статьи, опубликованные в журнале

---

• • 2023 Combination of an AGTR1 rs275651 polymorphism and plasma angiotensin II level as a pathogenic binary candidate biomarker to predict outcome in sepsis
  • Pisarev V.M., Chumachenko A.G., Ilyichev A.V., Grigoriev E.K., Grechko A.V.
  • в журнале Intensive Care Medicine Experimental, том 11, № 1, с. 486-486 DOI
• • 2023 Extracorporeal multimodal hemoperfusion with Efferon LPS to abrogate cell-free plasma DNA circulation in septic shock patients
  • Pisarev V.M., Rey S.I., Kulabukhov V.V., Popov A.Yu, Nikitina O.V., Berdnikov G.A., Magomedov M.A., Kim T.G., Masolitin S.V., Ignatenko O.V., Krotenko N.P., Marisheva A.N., Chaus N.I., Ohinko L.V., Mendibaev M.S., Chumachenko A.G., Kostyuk S.V., Ershova E.S., Grechko A.V.
  • в журнале Intensive Care Medicine Experimental, том 11, № 1, с. 402-402 DOI
• • 2022 Extracorporeal hemoperfusion with Efferon LPS for rapid reconstitution of vital parameters and decreasing proinfammatory biomarkers in patients with intra‑abdominal sepsis
  • Magomedov M., Kim T.G., Masolitin S.V., Pisarev V.
  • в журнале Intensive Care Medicine Experimental, № 40, с. 195-196 DOI
• • 2020 Critically ill patients with encephalitis in ICU
  • Luneva I., Polishchuk R., Ryabinkina Y., Piradov M.
  • в журнале Intensive Care Medicine Experimental, том 8, № S2, с. 580-580 DOI
• • 2020 Synocarotid syndrome in carotid angioplasty with stenting
  • Polishchuk R., Ryabinkina Y., Piradov M., Luneva I.
  • в журнале Intensive Care Medicine Experimental, том 8, № S2, с. 579-580 DOI
• 
  • 2019 Aseptic meningitis after carotid artery stenting
  • Luneva I.E., Ryabinkina Yu V., Piradov M.A.
  • в журнале Intensive Care Medicine Experimental, том 3, № 7, с. 116-117 DOI
• • 2019 Connection between biomarkers and indolic and phenolic metabolites in сerebrospinal fluid in critically ill patients
  • Chernevskaya E., Beloborodova N., Litvinova T., Alexandrova I., Getsina M., Pautova A.
  • в журнале Intensive Care Medicine Experimental, том 7, № S2
• 
  • 2019 Is antibiotic treatment always necessary for chronic critical ill patients?
  • Natalia Beloborodova, Irina Buyakova, Ekaterina Chernevskaya
  • в журнале Intensive Care Medicine Experimental, том 7, № S2, с. P3 DOI
• • 2018 IDENTIFICATION OF ENDOGENOUS BACTERIOPHAGES IN PATIENTS WITH BACTEREMIA AND SEPSIS - AN OBSERVATIONAL STUDY
  • Petrikov S.S., Shabanov A.K., Chernenkaya T.V., Lazareva E.V., Evdokimova N.V., Zhilenkov E.L., Kuzovlev A.N., Goloubev A.M., Grechko A.V.
  • в журнале Intensive Care Medicine Experimental, том 6, № S1, с. 20
• • 2018 Identification of endogenous bacteriophages in patients with bacteremia and sepsis - an observational study
  • Petrikov S.S., Shabanov A.K., Chernenkaya T.V., Lazareva E.V., Evdokimova N.V., Zhilenkov E.L., Kuzovlev A.N., Goloubev A.M., Grechko A.V.
  • в журнале Intensive Care Medicine Experimental, том 6, № S1, с. 20
• • 2018 Metabolic monitoring of patients in chronic critical illness after brain damage: a pilot study
  • Sergeev I., Petrova M., Krylov K., Shestopalov A., Yagubyan R., Sergienko A., Yakovleva A.
  • в журнале Intensive Care Medicine Experimental, том 6, № S2, с. 381-381
• • 2018 PERSONALIZED APPROACH TO EARLY PREDICTION OF INFECTIOUS COMPLICATIONS IN PATIENTS WITH SEVERE TRAUMA
  • Moroz V.V., Kuzovlev A.N., Boeva E.A., Zhanataev A.K., Durnev A.D., Reshetnyak V.I.
  • в журнале Intensive Care Medicine Experimental, том 6, № S1, с. 20
• • 2018 PRACTICE OF HEMOSORPTION WITH CYTOSORB ADSORBER FOR SEPSIS IN CANCER PATIENTS
  • USHAKOVA N.D.
  • в журнале Intensive Care Medicine Experimental, том 6, № 51, с. 22-22
• • 2018 Potential contribution of aromatic microbial metabolites to platelet aggregation disturbance
  • Chernevskaya E., Beloborodova, Bulychev A.
  • в журнале Intensive Care Medicine Experimental, том 6, № S1, с. P41
• • 2018 The first experience of targeted antibiotics for the regulation of the metabolic activity of the gut microbiota (MAGM) in critically ill patients with pneumonia or abdominal infection. 31th ESICM, France, Paris. 20-24 Oct 2018// — 2018. IF 0,17
  • Beloborodova N., Sarshor Yu
  • в журнале Intensive Care Medicine Experimental
• • 2017 FREQUENCY OF IDENTIFICATION AND RESULTS OF TREATMENT OF PATIENTS WITH PSEUDOMONAS AERUGINOSA (P. AERUGINOSA) IN A RUSSIAN CANCER RESEARCH CENTER IN 2011-2014
  • Obukhova O., Kurmukov I., Kashiya S.
  • в журнале Intensive Care Medicine Experimental, том 5, с. 355
• • 2016 SENSITIVITY AND SPECIFICITY OF NEW CLINICAL CRITERIA OF SEPSIS (QSOFA) IN PATIENTS RECEIVING ANTICANCER THERAPY
  • Obukhova O., Kashiya S., Kurmukov I.A., Pronina A.M.
  • в журнале Intensive Care Medicine Experimental, том 4, с. 151
• • 2016 SENSITIVITY OF BIOMARKERS OF SEPSIS IN PATIENTS RECEIVING ANTICANCER THERAPY
  • Obukhova O., Kurmukov I.A., Kashiya S.
  • в журнале Intensive Care Medicine Experimental, том 4, с. 233
• • 2015 AUTOMATIC SYSTEM OF DIAGNOSING AND TREATMENT IN INTENSIVE CARE UNIT
  • Solodova R., Sokolov M., Galatenko V., Petrova M.
  • в журнале Intensive Care Medicine Experimental, том 3, № Suppl 1, с. A729 DOI